Metraipolis › archive › dc_891ef3ef4c36

Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy — Europe PMC PMID:42602009

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42602009
DOI
10.3389/fimmu.2026.1886388
License (as archived)
solo-consultazione
Archived
2026-10-17T06:40:29.035Z
SHA-256 of the archived text
b29385a488c345aca598018b6bdcc494ae738d27aeab6175cadbecefc419282f
Stable URL of this page
https://metraipolis.com/documento/dc_891ef3ef4c36

How to cite

Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy — Europe PMC PMID:42602009 — Europe PMC (en), https://europepmc.org/article/MED/42602009 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_891ef3ef4c36 (Metraipolis archive dc_891ef3ef4c36, sha256 b29385a488c345aca598018b6bdcc494ae738d27aeab6175cadbecefc419282f)
BibTeX
@misc{dc891ef3ef4c36,
  title = {Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy — Europe PMC PMID:42602009},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42602009},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_891ef3ef4c36; sha256 b29385a488c345aca598018b6bdcc494ae738d27aeab6175cadbecefc419282f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602009. Agents can read the archived copy with the MCP tool read_document.